1
/
of
0
FDA Drug Approval, N211635, VALTOCO
FDA Drug Approval, N211635, VALTOCO
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 211635
Company: NEURELIS INC
Drug Name: VALTOCO
Active Ingredients: DIAZEPAM
Strength: 10MG/SPRAY
Dosage Form/Route: SPRAY;NASAL
Action Date: 01/10/2020
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Company: NEURELIS INC
Drug Name: VALTOCO
Active Ingredients: DIAZEPAM
Strength: 10MG/SPRAY
Dosage Form/Route: SPRAY;NASAL
Action Date: 01/10/2020
Marketing Status: Prescription
Submission Classification: Type 3 - New Dosage Form
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details